Marker molecules of lymphocytes in the diagnosis of immune-dependent disease-Reference-Cited by-同舟云学术

Marker molecules of lymphocytes in the diagnosis of immune-dependent disease

Published:2022-03-20 Issue:3 Volume: Page:27-39
ISSN:2075-0277
Container-title:Terapevt (General Physician)
language:
Short-container-title:General Physician

Author:

Pinelis Marina Leonidovna,

Abstract

One of the promising directions in modern immunology is the search, evaluation, and subsequent determination of the role of the most significant surface antigens expressed on immunocompetent cells in the implementation of a normal immune response and in pathology. The quantitative composition of leukocytes in peripheral blood is one of the factors for the successful implementation of their functional activity. Today, the flow cytometry method, which is widely used both in clinical and experimental immunology, makes it possible to analyze the activation processes of immunocompetent cells based on the identification of the main surface molecules, markers of the proliferative activity of immune system cells, apoptosis, and intercellular cooperation. HLA-DR cells are a marker of late and long-term activation of cells, they remain in the blood for a long time. Their study allows assessing the severity of the inflammatory process and monitoring the effectiveness of treatment: a dynamic decrease in this indicator indicates a decrease in the inflammatory response, while an increase shows the activation of the inflammatory process.

Publisher

PANORAMA Publishing House

Reference26 articles.

1. 1. Antoneeva I. I., Petrov S. B. Markery apoptoza i proliferatsii opukholevykh kletok v dina¬mike progressirovaniia raka iaichnika [Markers of apoptosis and proliferation of tumor cells in the dynamics of progression of ovarian cancer] // Onkologiia [Oncology]. - 2018. - Vol. 10, No. 2. - P. 234-237. (In Russ.)

2. 2. Artamonova E. V., Tupitsin N. N., Letiagin V. P. Retseptor transferrina (CD71) na kletkakh raka molochnoi zhelezy [Transferrin receptor (CD71) on breast cancer cells] // Molekuliarnaia meditsina [Molecular Medicine]. - 2017. - No. 1. - P. 16-20. (In Russ.)

3. 3. Baryshnikov A. Iu., Shishkin Iu. V. Immunologicheskie problemy apoptoza [Immunological problems of apoptosis]. - M.: Editoria, 2002. - 320 p. (In Russ.)

4. 4. Zhukova O. B., Riazantseva N. V., Novitskii V. V. Apoptoz i virusnaia infektsiia [Apoptosis and viral infection]. - Tomsk: Publishing House of the Tomsk University, 2016. - 142 p. (In Russ.)

5. 5. Zenin V. V., Aksenov N. D., Mitiushova E. V., Marakhova I. I. Poverkhnostnaia ekspressiia CD25 u limfotsitov cheloveka na raznykh stadiiakh zapuska proliferativnogo otveta. I. Rol tirozinkinaz semeistv JAK i Src po dannym ingibitornogo analiza [Surface expression of CD25 in human lymphocytes at different stages of triggering the proliferative response. I. The role of tyrosine kinases of the JAK and Src families according to inhibitory analysis] // Tsitologiia [Citology]. - 2011. - Vol. 53, No. 8. - P. 645-651. (In Russ.)